Success Story: Turning a NOID Around: EB-1A Success in Neuro-Biotechnology

Client’s Testimonial:

“I really appreciate your dedicated support along the journey.”

On November 26^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Principal Scientist in the Field of Biotechnology (Approval Notice).

General Field: Biotechnology

Position at the Time of Case Filing: Principal Scientist

Country of Origin: China

Country of Residence at the Time of Filing: Belgium

Approval Notice Date: November 26^th, 2025

Processing Time: 3 months, 12 days (Premium Processing Upgrade Requested)

Case Summary:

NAILG is pleased to share the story of an EB-1A approval for a biotechnology researcher whose work bridges neuroscience, virology, and regenerative medicine. His petition, filed under the extraordinary ability category, initially faced a Notice of Intent to Deny. After NAILG prepared a targeted response addressing each concern, USCIS approved the case 3 months and 12 days after filing and 1 month and 18 days after the NOID was issued, confirming his place among the top experts in his field.

From the outset, NAILG highlighted the client’s leadership in advancing fundamental knowledge of neurodevelopment, neurodegenerative disorders, and infectious disease mechanisms. His research has contributed valuable insights into viral neuropathogenesis, stem-cell biology, and biomaterial-guided neural repair. This work has been widely adopted by independent researchers seeking solutions to neurological injury, aging-related cognitive decline, and post-viral complications.

A major strength of the case was the client’s substantial scholarly footprint. He has authored 15 peer-reviewed journal articles, including 2 first-authored and 1 co-first-authored, in selective journals spanning neuroscience, stem-cell biology, and bioengineering. His work has been cited 1,401 times, and he holds an h-index of 13, placing him among the top performers in biotechnology. His findings have shaped global investigations into neuroinflammation, stem-cell rejuvenation, and tissue-engineering strategies. As one expert stated:

“[Client]’s expertise in biotechnologies, neurodevelopment, and neurodegenerative diseases and his many completed research projects substantiate his importance to the global recovery from the COVID-19 pandemic and developing approaches to confront many other neurologically related health concerns.”

In addition to his research contributions, the client demonstrated recognized authority through his service as a peer reviewer. He has completed at least 30 reviews for journals in neuroscience and biotechnology, an activity reserved for trusted subject-matter experts who are relied upon to assess the rigor, originality, and impact of cutting-edge research.

Despite the NOID, NAILG presented a compelling final merits narrative showing that the client is among the small percentage at the top of his discipline. His discoveries have been widely implemented across laboratories, cited by leading institutions, and extended into clinical guidelines and translational frameworks. His work continues to support new advancements in neurological medicine, regenerative biology, and infectious disease research.

NAILG is proud to have guided this case from filing through the NOID to final approval. The client’s EB-1A recognition reflects both his profound scientific influence and his ongoing potential to advance critical areas of U.S. biomedical research.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.